Last Updated: June 17, 2026
By: Brian Karr · Co-Founder & Chief Inspection Officer, We Inspect
Mold biotoxin illness is what happens when the immune system encounters mycotoxins from mold and cannot clear them. For people with specific HLA-DR gene variants, biotoxins accumulate rather than clear, triggering a systemic inflammatory cascade that disrupts the brain, hormones, and immune function simultaneously. Identifying and removing the environmental source has to come before any other treatment approach can work.
The medical term is Chronic Inflammatory Response Syndrome, or CIRS. Not an allergy. A biotoxin-mediated multi-system inflammatory disease with measurable biomarkers, tied to ongoing environmental exposure to mold and the mycotoxins mold produces.
Most people who end up calling us started somewhere else first — rheumatology, neurology, psychiatry, integrative medicine. They collected diagnoses that didn’t fit and took medications that moved some symptoms without clearing the picture. Understanding why starts with how the biotoxin pathway actually works. For the full symptom picture across all 13 organ systems CIRS can affect, see our complete guide to the signs of mold illness and CIRS.
What Makes Biotoxin Illness Different From a Typical Mold Reaction
The most important thing to understand about mold biotoxin illness is that it’s not a sensitivity reaction. A 2025 review in the International Journal of Creative and Systematic Research and Reviews estimates that 24–25% of the general population carries HLA-DR gene variants that prevent the immune system from identifying and tagging biotoxins for elimination — meaning for roughly one in four people, the standard clearance mechanism simply doesn’t engage.1
In people without these variants, mold mycotoxin exposure produces symptoms while they’re in the contaminated space. Leave the building, symptoms ease. The immune system identifies the threat, tags it, and clears it. Done.
For people with HLA-DR susceptibility, that clearance step fails. Biotoxins recirculate through the body rather than being excreted. Every subsequent exposure compounds the load. The immune system keeps firing at something it cannot resolve, and that sustained activation is what produces the multi-system symptom pattern — fatigue, cognitive disruption, hormonal dysregulation, pain — that patients describe but can’t trace back to any single cause.
Research published in the AIMS Allergy and Immunology journal confirmed that when this immune state goes untreated, Th2/Th17 polarization can progress to ME/CFS, triggered by a viral illness or vaccination as the chronically activated immune system loses its regulatory capacity.2 It doesn’t self-resolve. The biotoxin load has to be cut off at the source.
For a deeper look at how CIRS is defined medically and how it differs from other mold-related diagnoses, see our overview of what CIRS is and how it progresses.
How the Biotoxin Pathway Creates Chronic Illness
Mold produces mycotoxins as part of its biology. In water-damaged buildings, those mycotoxins become airborne and are inhaled. They enter the body and bind to receptors in the brain, gut, immune organs, and hormone-producing glands. In most people, the innate immune system detects, tags, and clears them. In genetically susceptible people, the biotoxin enters the body but never gets tagged for removal. It recirculates.
RNA-Seq analysis of CIRS patients, published in the Medical Research Archives in 2016, found that CIRS creates a measurable, distinct genomic signature in white blood cells — distinguishable from healthy controls with high accuracy. The same study identified molecular hypometabolism as a hallmark of untreated CIRS: a measurable suppression of cellular energy production that affects every system the patient says feels wrong.3
The downstream effects cascade. Biotoxin recirculation triggers cytokine release. Cytokines suppress melanocyte-stimulating hormone, which regulates sleep, pain sensitivity, immune balance, and gut permeability. MSH loss disrupts leptin and ADH signaling, affecting sleep, thirst, and body water regulation. VIP levels drop, altering pulmonary function and inflammation. Each downstream disruption produces symptoms that look like a completely separate problem. This is why these patients accumulate diagnoses.
A 2013 clinical study in the journal Toxins found that 93% of patients diagnosed with chronic fatigue syndrome tested positive for at least one mycotoxin in urine, with over 90% reporting a history of water-damaged building exposure — direct clinical evidence linking biotoxin body burden to the multi-system illness most clinicians still treat as psychiatric or idiopathic.4
Why Genetic Susceptibility Determines Who Gets Sick
One of the most disorienting aspects of biotoxin illness is what happens within the same household. Two people breathing the same air can have completely different health outcomes. Research published in Mycotoxin Research in 2024 documented this directly: four clinical cases showed that the same mycotoxin exposure produced dramatically different illness severity depending entirely on HLA haplotype — two people with identical exposures diverging sharply based on genetics alone.5
I hear this dynamic almost every week on consultation calls. A man in Chicago reached out last year after spending two years getting passed between specialists. He was 41, had been diagnosed with fibromyalgia, then chronic fatigue syndrome, then referred to psychiatry when nothing held. His wife, living in the same house for the same two years, felt mostly fine. That asymmetry — one person deteriorating and one person not — is so consistent in CIRS cases that it’s practically a diagnostic signal in itself.
Understanding the genetic component removes the self-blame from the equation. It also explains why so many people describe their experience the same way: “I feel like I’ve been poisoned.” Because in a very real biochemical sense, that’s what’s happening. The body is carrying a load it was never equipped to clear.
This is also why standard air tests keep coming back negative. They’re measuring floating spore counts at one moment in time — a metric that captures population-level allergen exposure, not the individual’s inability to process biotoxins. The person can be severely ill while the test shows a clean result, which is exactly what most of our callers have already been through.
Why Biotoxin Illness Is So Hard to Diagnose
A 2024 review in the Annals of Medicine and Surgery confirmed what most CIRS patients already know from years of frustrated appointments: CIRS is commonly misdiagnosed as ME/CFS and fibromyalgia. The review described it as a “silent epidemic” and found that of all published treatment studies, the Shoemaker Protocol was identified as the framework in 11 of 13 articles reviewed — and yet most internists have never heard of it.6
The problem isn’t that CIRS is undetectable. It’s that the relevant biomarkers require specific testing — C4a, TGF-β1, MMP-9, MSH, VIP, ACTH, leptin, and ADH — that a standard complete blood count or comprehensive metabolic panel won’t capture. Patients spend years with inflammatory processes they can feel but cannot document on any lab result their physicians order.
The environmental side is equally opaque. Mold in water-damaged buildings often lives inside wall cavities, beneath flooring, inside HVAC ductwork, and behind finishes — invisible to anyone walking through the space. A floating spore count won’t find it. A visual inspection often won’t find it. Source-level sampling that maps where active mold growth is occurring in the structure is the only method that reliably identifies what’s driving a person’s biotoxin load. For a full breakdown of what CIRS biomarker testing involves and what to request from your doctor, see our guide on CIRS testing and how to get it ordered.
Can Biotoxin Illness Improve After Source Removal?
Yes. The clinical evidence for recovery is real. A 2013 systematic review published in The Scientific World Journal analyzed outcomes for mold illness patients and found that 27 of 28 patients returned to work following appropriate treatment — but the prerequisite in every case was eliminating the exposure source first.7 Detox protocols, VIP treatment, and anti-inflammatory interventions all produced outcomes. Not before the source was identified and removed, but after.
The biotoxin pathway can be interrupted. When the exposure stops and the biotoxin load begins to clear, the downstream hormone and immune cascades start to normalize. MSH levels recover. ADH signaling stabilizes. Patients who describe years of progressive decline report meaningful, measurable improvement after source removal — not overnight, but month by month, as the body stops fighting something it can now finally stop carrying. The body can heal. It just cannot heal while the exposure continues.
This is why source identification is the starting point, not one item on a long checklist. You cannot detox faster than you’re being re-exposed. You cannot supplement your way out of an active biotoxin load. The source has to be located with enough specificity to fix it precisely — mapped to the wall cavity, the HVAC component, the crawl space — so that remediation targets the right locations and doesn’t waste money on areas that aren’t driving the problem. For more on what the recovery process involves from this point, see our articles on what CIRS recovery actually looks like and why source removal must come first in any CIRS treatment plan.
Key Takeaways
- Mold biotoxin illness (CIRS) is not an allergy. It is a genetic susceptibility condition where mycotoxins recirculate rather than clear, driving sustained inflammation across multiple organ systems simultaneously.
- Roughly 24–25% of the general population carries HLA-DR gene variants that disable normal biotoxin clearance — explaining why two people in the same home can have completely different health trajectories.
- Standard blood panels (CBC, CMP, thyroid) do not test for CIRS biomarkers. Specific markers including C4a, TGF-β1, MMP-9, MSH, and VIP are required to document what the condition is actually disrupting.
- Recovery is documented. 27 of 28 mold illness patients returned to work in peer-reviewed outcome data — but source identification and removal had to precede treatment for outcomes to hold.
- The environmental source must be found before treatment can work. Source-level exposure mapping is the non-negotiable first step — without it, treatment addresses the body while the exposure continues.
Mold biotoxin illness is one of the most under-recognized chronic conditions in modern medicine — not because the science is unclear, but because connecting environmental exposure to a genetic susceptibility most people don’t know they have requires a different kind of investigation than most clinicians are equipped to order. If your symptoms vary based on where you are, if one person in your household is struggling while another feels fine, if you’ve accumulated diagnoses that explain some things but not the whole picture — the biotoxin pathway is a documented, medically coherent explanation worth pursuing.
The first step isn’t more labs. It’s finding out what your home is actually doing to your body.
Next Steps
If you want to know what your home is actually doing to your body, we can find out. We Inspect uncovers hidden mold contamination, ranks what truly drives your exposure, and delivers a contractor-ready Remediation Recovery Blueprint designed to meaningfully reduce exposure so your body can heal — without wasting tens of thousands on unnecessary fixes that won’t move the needle. Get My Free Exposure Consultation
Frequently Asked Questions
What is mold biotoxin illness?
Mold biotoxin illness, also called Chronic Inflammatory Response Syndrome (CIRS), is a multi-system inflammatory condition triggered by exposure to mold mycotoxins. In genetically susceptible people — roughly 24–25% of the population — the immune system cannot clear these biotoxins, leading to sustained inflammation affecting the brain, hormones, immune function, and multiple organ systems.
How do I know if I have biotoxin illness from mold?
Biotoxin illness produces a wide symptom cluster including fatigue, cognitive difficulty, joint pain, light sensitivity, chronic sinus congestion, and mood changes. Specific biomarkers — C4a, TGF-β1, MMP-9, MSH, VIP — can document CIRS when ordered by a knowledgeable clinician. Many patients first notice symptoms improve significantly when they spend extended time away from home.
Why do some people get sick from mold and others in the same house don’t?
Approximately 24–25% of the population carries HLA-DR gene variants that prevent the immune system from tagging biotoxins for elimination. People with these variants accumulate biotoxins with each exposure rather than clearing them. Two people in the same water-damaged home can have completely different health outcomes — one with progressive multi-system illness, the other with minimal symptoms — based entirely on this genetic difference.
Can biotoxin illness resolve on its own without treatment?
In people with HLA-DR susceptibility, biotoxin illness does not self-resolve. The immune system cannot clear the biotoxin load without intervention, and continued exposure worsens the condition over time. Research shows it can progress to ME/CFS if untreated. Recovery requires eliminating the environmental source and working through an appropriate treatment protocol with a knowledgeable clinician.
What does a mold inspection find that standard air tests miss?
Air tests measure spores floating in the air at one moment in time. They miss mold growing inside walls, under floors, and in HVAC systems — which is where most active mold growth actually lives in water-damaged buildings. Source-level sampling maps where active growth is occurring in the structure, giving remediation contractors specific locations to address rather than a general recommendation to treat everywhere.
References
- Rao TR, Sravya G, Kaushik T, Akshaya D. Chronic Inflammatory Response Syndrome (CIRS): A Review of Diagnosis, Immunological Mechanisms and Treatment Challenges. International Journal of Creative and Systematic Research and Reviews. 2025;8(7). doi:10.47191/ijcsrr/v8-i7-09
- Tuuminen T, Lohi J. Immunological and toxicological effects of bad indoor air to cause Dampness and Mold Hypersensitivity Syndrome. AIMS Allergy and Immunology. 2018;2(4):190. doi:10.3934/Allergy.2018.4.190
- Shoemaker RC. RNA-Seq on patients with chronic inflammatory response syndrome (CIRS) treated with vasoactive intestinal peptide (VIP) shows a shift in metabolic state and innate immune functions that coincide with healing. Medical Research Archives. 2016;4(7). doi:10.18103/MRA.V4I7.862
- Brewer JH, et al. Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins. 2013;5(4):605–617. doi:10.3390/toxins5040605
- Saghir S, Ansari RA. HLA gene variations and mycotoxin toxicity: Four case reports. Mycotoxin Research. 2024;40:57–68. doi:10.1007/s12550-023-00517-y
- Dooley M, Vukelic A, Jim L. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment. Annals of Medicine and Surgery. 2024. doi:10.1097/MS9.0000000000002718
- Hope J. A Review of the Mechanism of Injury and Treatment Approaches for Illness Resulting from Exposure to Water-Damaged Buildings, Mold, and Mycotoxins. The Scientific World Journal. 2013;2013:767482. doi:10.1155/2013/767482
This article is for informational purposes only and does not constitute professional medical advice. If you believe mold or other environmental hazards may be affecting your health, consult your healthcare provider.